Advertising disclosure: this site contains affiliate links. We may earn a commission at no extra cost to you. Learn more.
Weight Loss · Guide

Wegovy Results Timeline: What to Expect Week by Week

Weight Loss illustration

Key takeaways

  • Month 1 is for tolerance: 1 to 3 percent loss is on schedule.
  • Five percent by months 3 to 4 is the clinically meaningful marker.
  • Trials average ~15 percent by 68 weeks at 2.4 mg; Wegovy HD (2026) pushes higher.
  • Plateaus are normal physiology and a strategy point, not failure.
  • Protein, strength work and sleep decide the quality of every kilo lost.

The most common Wegovy question is not whether it works, trials settled that, but when. Here is the realistic timeline, mapped from the clinical data, so you can judge your progress against evidence instead of against strangers on the internet.

Weeks 1 to 4: the adjustment phase

Wegovy starts at 0.25 mg, a deliberately tiny dose designed for tolerance, not results. Expect appetite to quiet noticeably, food noise often drops early, and expect the gut to complain: nausea and constipation peak in these weeks. Weight loss is typically modest, one to three percent, and that is on schedule, not failure.

The mistake to avoid now: judging the drug by month one. The dose ladder has barely begun.

Months 2 to 4: the ladder climbs

Doses step up every four weeks (0.5, 1, 1.7 mg) as tolerated. Most users see steady loss in this window, commonly reaching five percent or more of body weight by month three or four, the threshold doctors consider clinically meaningful. Each dose bump can briefly revive nausea; food strategy (smaller, slower, less grease) earns its keep.

This is also the window to lock in protein targets and strength training, because the composition of your loss is being decided now.

Enjoy clear, no-hype health guides? Get our free weekly digest.Subscribe free

Months 4 to 16: the deep phase

At the full 2.4 mg dose, trial participants averaged around 15 percent total loss by 68 weeks, with the curve flattening toward a plateau in the second year. Real-world results vary widely around that average: some exceed 20 percent, a minority respond little.

New in 2026: Wegovy HD, a 7.2 mg high-dose version approved in March, pushed average losses meaningfully higher in trials, giving prescribers another rung for strong responders who plateau early. Plateaus themselves are normal physiology, not proof the drug quit: they are where dose review, habits audit or maintenance conversations happen.

What speeds results up, and what stalls them

The takeaway

Wegovy is a 12-to-16-month story, not a 4-week one: quiet appetite first, meaningful loss by month three or four, averages near 15 percent over a year-plus, and a plateau that invites strategy rather than despair. Judge yourself against the timeline, not against highlight reels.

Frequently asked questions

How fast will I lose weight on Wegovy?

Typical trial pattern: 1 to 3 percent in the first month, around 5 percent by months 3 to 4, and an average near 15 percent by 68 weeks at full dose, with wide individual variation.

Why am I not losing on Wegovy?

Common reasons: still on early doses, calorie-dense grazing, poor sleep, or being among the minority of low responders. Review with your prescriber before concluding anything.

What is Wegovy HD?

A higher 7.2 mg dose approved in March 2026 for adults needing greater effect, delivering larger average losses in trials: a prescriber option, not a starting point.

Read next

This article is for general informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your individual situation, and never start or stop a medication without your doctor. See our Medical Disclaimer.